Tianwei Chen

873 total citations
25 papers, 421 citations indexed

About

Tianwei Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tianwei Chen has authored 25 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Tianwei Chen's work include RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Healthcare and Venom Research (3 papers). Tianwei Chen is often cited by papers focused on RNA modifications and cancer (5 papers), Ubiquitin and proteasome pathways (4 papers) and Healthcare and Venom Research (3 papers). Tianwei Chen collaborates with scholars based in China, United States and Australia. Tianwei Chen's co-authors include Dong Xie, Ning Ma, Er‐Bin Zhang, Dongxian Guan, Lin Qiu, Shuqun Cheng, Qian‐Zhi Ni, Xufen Ding, Mengmeng Liu and Yanmei Yuan and has published in prestigious journals such as Nature Communications, Hepatology and Oncogene.

In The Last Decade

Tianwei Chen

25 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianwei Chen China 11 247 133 87 55 54 25 421
Boyun Shi China 13 317 1.3× 206 1.5× 72 0.8× 80 1.5× 36 0.7× 16 439
Junjian Deng China 12 275 1.1× 173 1.3× 99 1.1× 40 0.7× 31 0.6× 24 399
Xiuling Li China 14 228 0.9× 145 1.1× 108 1.2× 55 1.0× 22 0.4× 29 468
Yuquan Tao China 11 313 1.3× 230 1.7× 98 1.1× 53 1.0× 50 0.9× 14 524
Ying Cheng China 15 238 1.0× 174 1.3× 117 1.3× 61 1.1× 27 0.5× 48 605
Jiong Yang China 9 244 1.0× 132 1.0× 81 0.9× 25 0.5× 26 0.5× 14 415
Jingsun Wei China 9 192 0.8× 145 1.1× 103 1.2× 44 0.8× 21 0.4× 22 394
Zhen Zhu China 12 268 1.1× 124 0.9× 113 1.3× 34 0.6× 25 0.5× 23 464

Countries citing papers authored by Tianwei Chen

Since Specialization
Citations

This map shows the geographic impact of Tianwei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianwei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianwei Chen more than expected).

Fields of papers citing papers by Tianwei Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianwei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianwei Chen. The network helps show where Tianwei Chen may publish in the future.

Co-authorship network of co-authors of Tianwei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tianwei Chen. A scholar is included among the top collaborators of Tianwei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianwei Chen. Tianwei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Tianwei, et al.. (2025). A comprehensive analysis of molecular characteristics of hot and cold tumor of gastric cancer. Cancer Immunology Immunotherapy. 74(3). 102–102. 1 indexed citations
2.
Yang, Yan, Fei Chen, Haoran Wei, et al.. (2024). RPL36A activates ERK pathway and promotes colorectal cancer growth. Translational Oncology. 51. 102170–102170. 2 indexed citations
3.
Chen, Tianwei, et al.. (2024). Breathing new insights into the role of mutant p53 in lung cancer. Oncogene. 44(3). 115–129. 14 indexed citations
4.
Chen, Tianwei, et al.. (2023). The predictive value of baseline symptom score and the peripheral CD4CD8 double-positive T cells in patients with AECOPD. BMC Pulmonary Medicine. 23(1). 478–478. 2 indexed citations
5.
6.
Shi, Qian, Ying He, Jingjing Li, et al.. (2023). RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3. Journal of Translational Medicine. 21(1). 418–418. 12 indexed citations
7.
Zhou, Lingxiao, Tianwei Chen, Qiyuan Wang, et al.. (2023). Anlotinib plus camrelizumab achieved long‐term survival in a patient with metastatic esophageal neuroendocrine carcinoma. Cancer Reports. 6(9). e1855–e1855. 5 indexed citations
8.
Wang, Yikang, Ning Ma, Sheng Xu, et al.. (2023). PPDPF suppresses the development of hepatocellular carcinoma through TRIM21-mediated ubiquitination of RIPK1. Cell Reports. 42(4). 112340–112340. 9 indexed citations
9.
Chen, Tianwei, Xilin Zhang, Xufen Ding, et al.. (2022). Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS / BACH1 axis. Molecular Oncology. 17(4). 695–709. 10 indexed citations
10.
Ding, Xufen, Tianwei Chen, Qian Shi, et al.. (2021). INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling. Experimental Cell Research. 407(2). 112826–112826. 7 indexed citations
11.
Zhang, Er‐Bin, Xiuping Zhang, Kang Wang, et al.. (2021). Antifungal agent Terbinafine restrains tumor growth in preclinical models of hepatocellular carcinoma via AMPK-mTOR axis. Oncogene. 40(34). 5302–5313. 21 indexed citations
12.
Zhou, Bin, Tianwei Chen, Yabo Jiang, et al.. (2020). Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma. Oncology Letters. 19(3). 2011–2020. 3 indexed citations
13.
Song, Chao, Tianwei Chen, Lan He, et al.. (2019). PRMT1 promotes pancreatic cancer growth and predicts poor prognosis. Cellular Oncology. 43(1). 51–62. 51 indexed citations
14.
Yuan, Yanmei, Ning Ma, Er‐Bin Zhang, et al.. (2019). BMP10 suppresses hepatocellular carcinoma progression via PTPRS–STAT3 axis. Oncogene. 38(48). 7281–7293. 14 indexed citations
15.
Chen, Tianwei, Yanmei Yuan, Dongxian Guan, et al.. (2019). CHML promotes liver cancer metastasis by facilitating Rab14 recycle. Nature Communications. 10(1). 2510–2510. 33 indexed citations
16.
17.
Wu, Ying, Bo Shan, Jianli Dai, et al.. (2018). Dual role for inositol‐requiring enzyme 1α in promoting the development of hepatocellular carcinoma during diet‐induced obesity in mice. Hepatology. 68(2). 533–546. 56 indexed citations
18.
Yuan, Yin, et al.. (2017). [Effect of Moxibustion on Serum IL-17 and TNF-α Levels in Collagen-induced Arthritis Rats].. PubMed. 42(2). 149–52. 4 indexed citations
19.
Jiang, Hao, Ning Ma, Wentao Zhou, et al.. (2016). Triosephosphate isomerase 1 suppresses growth, migration and invasion of hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications. 482(4). 1048–1053. 48 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boyun Shi Breakdown of academic impact, for papers by Junjian Deng Breakdown of academic impact, for papers by Xiuling Li Breakdown of academic impact, for papers by Yuquan Tao Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Jiong Yang Breakdown of academic impact, for papers by Jingsun Wei Breakdown of academic impact, for papers by Zhen Zhu
Rankless by CCL
2026